再鼎医药（09688）今日盘中大跌5.30%，引发市场关注。该股价下跌或与美国前总统特朗普最新宣布的药价政策有关。
据报道，特朗普计划签署一项重磅行政令，要求美国处方药价格与全球最低价格国家看齐。特朗普表示，这一政策可能导致美国处方药和药品价格几乎立即下降30%至80%。这一消息引发了全球医药股的普遍下跌，日本药品指数周一下跌3.9%。
作为一家专注于创新疗法的生物制药公司，再鼎医药的股价受到此消息的显著影响。分析人士指出，如果该政策得以实施，可能会对全球制药公司的收入和研发投入产生重大影响。虽然政策细节尚未公布，但市场对制药行业的前景普遍持谨慎态度，这可能是导致再鼎医药股价大幅下跌的主要原因。投资者需密切关注该政策的进一步发展及其对全球医药市场的潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.